Travere Therapeutics
The Rare Kidney Disease Educator at Travere Therapeutics plays a pivotal role in educating and empowering underserved communities impacted by Focal Segmental Glomerulosclerosis (FSGS) and IgA Nephropathy (IgAN). The position involves leading patient education, building disease awareness, and connecting patients to resources and advocacy groups. This role requires collaboration with cross-functional teams and local stakeholders to improve care access and address health disparities in at-risk populations.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2020
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.
How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall
1 day ago
Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)
3 days ago
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Travere Therapeutics.
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory
2 weeks ago
Rare Disease Sales Specialist
Vera Therapeutics, Inc.
Regional Sales Director (RSD), IgAN/aHUS
AstraZeneca
Rare Disease Specialist
Soleno Therapeutics
Kidney Territory Account Manager (North and South Dakota)
Vertex
Regional Sales Director (RSD), IgAN/aHUS
AstraZeneca
Regional Sales Director (RSD), IgAN/aHUS
AstraZeneca